Candle Pharmaceuticals LLP - pharma in Chandigarh, India. FY 2026 financials & compliance.
LLPIN AAM-1584 Incorporated 05 March 2018 ROC Chandigarh HQ Chandigarh, India
Active Limited Liability Partnership pharma
Revenue · FY 2019
₹4.4 Lakh
Latest filing
Net loss · FY 2019
₹1.36 Lakh
Net margin -31%
EBITDA · FY 2019
₹4.4 Lakh
EBITDA margin 100.1%
Contribution obligation
₹1 Lakh
As per LLP agreement
LLP age
8 yrs
Est. 2018
Designated partners
2
As per MCA filings
Active GSTINs
1
GST registered
Last financials
Mar 2025
Balance sheet date

About Candle Pharmaceuticals LLP

Data last updated:

Candle Pharmaceuticals LLP is a limited liability partnership (LLP) based in Chandigarh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 05 March 2018 and has been in existence for over 8 years.

The LLP is registered with the Registrar of Companies (ROC), Chandigarh, under LLPIN AAM-1584. Its GSTIN is 04AANFC2741B1ZZ (Chandigarh).

The LLP has a total obligation of contribution of ₹1 Lakh. It is led by designated partners Sachin Dhingra and Suhail Singh Puri.

Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at SCO 909 First Floor Nac Manimajra, Chandigarh, India – 160101.

As per the financials filed for FY 2019, the LLP reported a revenue of ₹4.4 Lakh. For the same year it recorded a net loss of ₹1.36 Lakh (net margin -31%) and EBITDA of ₹4.4 Lakh (EBITDA margin 100.1%).

Court records list 3 cases involving the LLP, including 1 filed by the LLP and 2 filed against it; 1 case is pending.

For more details, the LLP can be reached via its website candlepharma.com.

Company details

LLPIN AAM-1584
Incorporation Date 05 March 2018
Total Obligation of Contribution ₹1 Lakh
ROC Chandigarh
Company Status Active

Contact details

Candle Pharmaceuticals LLP's registered office is in Chandigarh, Chandigarh. Its website is candlepharma.com. Its e-mail address is in the company report.

  • Email
  • Registered Address
    SCO 909 First Floor Nac Manimajra, Chandigarh, India – 160101
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Candle Pharmaceuticals LLP, buy the company report.

Comprehensive company report
Candle Pharmaceuticals LLP - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Candle Pharmaceuticals LLP

FY 2025 filings available

Candle Pharmaceuticals LLP reported revenue of ₹4.4 Lakh for FY 2019.

Revenue · FY 2019
₹4.4 Lakh
Net loss · FY 2019
₹1.36 Lakh margin -31%
EBITDA · FY 2019
₹4.4 Lakh margin 100.1%

Financial Statement Summary

Statement of Account and SolvencyFY 2018-19FY 2017-18
Income and Expenditure
Turnover₹4.4 Lakh
Other Income
Total Income
Purchases and Direct Costs
Personnel Expenses
Administrative Expenses
Interest
Depreciation
Total Expenses
Profit Before Tax
Tax
Profit After Tax-₹1.36 Lakh
Profit Transferred to Partners
Assets and Liabilities
Partners' Contribution
Reserves and Surplus
Secured Loans
Unsecured Loans
Trade Payables
Other Liabilities and Provisions
Total Liabilities
Fixed Assets
Investments
Loans and Advances
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

Statement of Account and SolvencyFY 2018-19FY 2017-18
Profitability
Net Profit Margin-31%
Return on Partners' Funds
Return on Assets
Liquidity and Debt
Current Ratio
Debt to Partners' Funds
Interest Coverage
Efficiency and Growth
Asset Turnover
Receivable Days
Turnover Growth
Profit Growth

To see the full financial statements and ratios of Candle Pharmaceuticals LLP, buy the company report.

Designated partners of Candle Pharmaceuticals LLP

Candle Pharmaceuticals has 2 current designated partners and 3 former designated partners. Current designated partners are listed first, with their designation and appointment date.

Current Designated Partners
NameDesignationAppointment DateTenureStatus
Sachin DhingraDesignated Partner05 Mar 20188 Years 8 MonthsCurrent
Suhail Singh PuriDesignated Partner22 Sep 20251 Years 1 MonthsCurrent

MSME payment delays

No delayed payments to MSME suppliers are on our record for Candle Pharmaceuticals LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Candle Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
04AANFC2741B1ZZChandigarhActive03 May 2018

To see the full GST registrations and return filing status of Candle Pharmaceuticals LLP, buy the company report.

Recent activity

Candle Pharmaceuticals LLP has 5 designated partner changes on record since 2018: 4 appointments and 1 cessation. The latest: Suhail Singh Puri was appointed as Designated Partner on 22 Sep 2025.

Appointed
Suhail Singh Puri was appointed as Designated Partner.
AGM
Candle Pharmaceuticals Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records.
Filing
Candle Pharmaceuticals Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh.
Appointed
Kapil Madan was appointed as Designated Partner.
Appointed
Lohit Bindra was appointed as Designated Partner.
Ceased
Suhail Singh Puri ceased to be Designated Partner.
Appointed
Sachin Dhingra was appointed as Designated Partner.
Incorporation
05 Mar 2018
Candle Pharmaceuticals Llp was registered on 05 Mar 2018 with Roc Chandigarh & aged 8 years 8 months as per MCA records.

Frequently asked questions

Candle Pharmaceuticals is an active limited liability partnership based in Chandigarh, India. The LLP works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 05 March 2018 (8+ years old) and is registered under LLPIN AAM-1584.

Candle Pharmaceuticals has 2 current designated partners:

The latest financial statements of Candle Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 March 2025. Year-wise statements from FY 2018 are in the company report.

The GSTIN of Candle Pharmaceuticals is 04AANFC2741B1ZZ, registered in Chandigarh.

The LLPIN (Limited Liability Partnership Identification Number) of Candle Pharmaceuticals is AAM-1584. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.

Candle Pharmaceuticals has 3 court cases on record: 1 filed by the LLP and 2 filed against it. 1 is pending.

Candle Pharmaceuticals was incorporated on 05 March 2018, making it 8+ years old. It is registered with the Registrar of Companies, Chandigarh.

Suhail Singh Puri was appointed as Designated Partner on 22 Sep 2025. Kapil Madan was appointed as Designated Partner on 31 Mar 2023. Lohit Bindra was appointed as Designated Partner on 19 Nov 2019. Candle Pharmaceuticals has 5 designated partner changes on record in total.

Candle Pharmaceuticals can be reached through the website candlepharma.com. Its registered office is in Chandigarh, India.

The registered office of Candle Pharmaceuticals is at SCO 909 First Floor Nac Manimajra, Chandigarh, India – 160101.